Both in Surgical Instruments
PAVmed vs Cytosorbents
Over the past year PAVM returned −84.7% and CTSO returned −72.7%; their daily moves had a correlation of 0.08.
PAVM −84.7% CTSO −72.7%Growth of $1, one year, split-adjusted
| Metric | PAVM | CTSO |
|---|---|---|
| Price | $1.84 | $4.26 |
| Market cap | $14.7M | $13.4M |
| Today | −3.66% | +3.32% |
| 1 month | −30.8% | +7.4% |
| 6 months | −77.1% | −64.8% |
| Year to date | −72.2% | −66.7% |
| 1 year | −85.7% | −73.2% |
| Revenue growth (YoY) | +450.0% | +0.2% |
| Gross margin | −269.7% | 73.2% |
| Net margin | −16603.0% | −45.9% |
| P/E (TTM) | — | — |
| Price / sales | 131.4× | 0.4× |
| Net cash | -$11.3M | -$12.8M |
| Dividend yield | — | — |
| Volatility (60d) | 100.4% | 881.2% |
| Short % of float | 0.3% | 0.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).